Table 2

Prevalence of taste disorders (TD) and smell disorders (SD) and their clinical baseline characteristics

Patients without SD or TDPatients with TD onlyPatients with SD onlyPatients with TD and SDP value
Total, n (%)384 (56.0)131 (19.1)15 (2.2)156 (22.7)
Age, (mean±SD)39±1239.47±12.4143.33±9.8239.60±10.750.597
Age groups, n (%)0.338
 <18 years12 (3.1)3 (2.3)0 (0)4 (2.6)
 18–30 years74 (19.3)33 (25.2)1 (6.7)24 (15.4)
 31–40 years124 (32.3)38 (29)6 (40.0)65 (41.7)
 41–50 years99 (25.8)28 (21.4)5 (33.3)34 (21.8)
 51–60 years70 (18.2)24 (18.3)2 (13.3)26 (16.7)
 >60 years5 (1.3)5 (3.8)1 (6.7)3 (1.9)
Gender, n (%)0.010
 Male233 (60.7)a62 (47.3)b9 (60)a,b75 (48.1)b
 Female151 (39.3)a69 (52.7)b6 (40)a,b81 (51.9)b
Smoking status, n (%)0.634
 Never smoked289 (75.3)111 (84.7)12 (80)128 (82.1)
 Smoked95 (24.7)20 (15.3)3 (20)30 (17.9)
Systemic disease
 None343 (70.9)112 (85.5)12 (80)133 (85.3)0.243
 Hypertension17 (4.4)10 (7.6)2 (13.3)8 (5.1)0.196
 Diabetes8 (2.1)4 (3.1)0 (0)3 (1.9)0.817
 Heart disease6 (1.6)1 (0.8)0 (0)3 (1.9)0.804
 Kidney disease1 (0.3)1 (0.8)0 (0)1 (0.6)0.431
  • P value obtained using one-way ANOVA test for quantitative variables and χ2 test for qualitative variables. The comparison of the distribution of age and systemic disease were tested by Fisher’s exact test.

  • Significant p values in bold.

  • Subscript letter (a and b) denotes a subset of group categories whose gender proportions do not differ significantly from each other at the 0.05 level.

  • ANOVA, analysis of variance.